This site is intended for health professionals only

Morphine “may make cancers worse”

teaser

Powerful opium-based morphine painkillers may actually make cancers worse for thousands of patients who routinely receive them, according to US research.

But scientists have also found that methylnaltrexone (MNTX), which was developed in the 1980s and approved for use in the US last year, can block this unwelcome side-effect without affecting morphine’s pain-killing properties.

The researchers, at the University of Chicago, found that morphine may fuel the growth and spread of cancer tumours.

Article continues below this sponsored advert
Featured Image
Explore the latest advances in cardiovascular care delivered by renowned experts from recognised Centres of Excellence and other NHS trusts around the UK. Gain CPD, put your burning questions to the experts, and boost your confidence when it comes to care for your patients.
Advertisement

Says the university’s Dr Patrick Singleton: “If confirmed clinically, MNTX could change how we do surgical anaesthesia for our cancer patients.

“It also suggests potential new applications for this novel class of drugs, which should be explored.”

Copyright Press Association 2009

Methylnaltrexone






Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine

x